Skip to main content

Novel Uses of IHC in Breast Pathology, Interpretation and Pitfalls - Ashley Cimino-Mathews, MD

Original release date:
 April 21, 2020
Access to this course expires on:  March 4, 2023 at 11:59 PM Pacific Time
CME .5

Faculty: Ashley Cimino-Mathews, MD

Learning Objectives:
  1. Describe the use of IHC in classification of metastases to the breast or a cancer of unknown primary
  2. Understand the use of PD-L1 IHC as an emerging biomarker in triple negative breast cancer